Feeling persistently cold is one of the most common but least discussed complaints among people being treated for cancer, and it rarely has a single cause. Cancer and its treatments disrupt temperature regulation through overlapping pathways: anemia reduces the blood’s ability to carry warmth to the extremities, chemotherapy drugs can rewire nerve responses to cold, muscle and fat loss strip away insulation, and hormonal shifts can throw the body’s internal thermostat off balance. The result is a kind of compounding chill that can persist across seasons and treatments, driven by biology rather than imagination.
How Cancer Itself Disrupts Body Temperature
Even before treatment begins, cancer can interfere with how the body maintains warmth. Tumors are metabolically demanding, siphoning nutrients and energy from the rest of the body. As the disease progresses, many patients develop cancer-related anemia, where the number of red blood cells drops because of chronic inflammation, nutritional deficits, or the tumor’s direct effects on bone marrow. Fewer red blood cells means less oxygen delivery to tissues, and the body responds by prioritizing blood flow to vital organs. Hands, feet, and skin get less circulation, and the person feels cold.
There is also a more direct thermoregulatory mechanism at play. The hypothalamus, the brain region that acts as the body’s thermostat, is sensitive to inflammatory signals called cytokines. Tumors and the immune system’s response to them produce cytokines in abundance. Research has shown that these signals can shift the hypothalamic set point for body temperature, meaning the brain may behave as if the body needs to conserve heat even when the person’s actual core temperature is normal or elevated. The feeling of being cold can persist because the brain is essentially recalibrating what “warm enough” means.1AACR Journals (Cancer Immunology Research). Temperature Matters! And Why It Should Matter to Tumor Immunologists
Circadian rhythm disruption adds another layer. The suprachiasmatic nucleus in the brain coordinates daily fluctuations in body temperature, hormone release, and immune activity. Cancer and cancer treatment have been shown to disrupt this circadian machinery, flattening the normal temperature rhythms that help the body stay warm during waking hours and cool down during sleep.2PubMed Central. Circadian disruption and cancer- and treatment-related symptoms When that rhythm loses its shape, temperature regulation becomes erratic, and feeling cold at odd times of day becomes more common.
Chemotherapy and Cold Sensitivity
Chemotherapy is probably the biggest single contributor to cold intolerance in cancer patients, and it works through several distinct mechanisms. One of the most striking is chemotherapy-induced peripheral neuropathy, or CIPN. More than half of patients receiving certain classes of chemotherapy drugs, particularly those based on taxanes, platinum compounds, or vinca alkaloids, develop nerve damage in their hands and feet.3Supportive Care in Cancer. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial The symptoms include numbness, tingling, pain, and a heightened sensitivity to cold. For many patients, touching a cold surface or drinking a chilled beverage becomes genuinely painful.
Oxaliplatin, a platinum-based drug widely used for colorectal cancer, is infamous for causing acute cold hypersensitivity. Unlike the gradual nerve damage seen with other drugs, oxaliplatin can trigger cold-related pain within hours of an infusion. The mechanism is now well studied: the drug and its breakdown products alter the expression of ion channels in sensory neurons. Specifically, oxaliplatin increases the activity of cold-sensing channels like TRPM8 and TRPA1 while suppressing potassium channels that normally dampen nerve excitability.4PubMed Central. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors5PubMed. Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity The net effect is that sensory neurons become far more excitable in response to cool temperatures, so even mildly cold air or surfaces register as intense discomfort.
Research into the molecular details has identified that oxaliplatin’s metabolite oxalate drives much of this acute response by disrupting calcium and sodium signaling in nerve cells. This triggers a cascade that ultimately ramps up the expression of TRPM8, one of the primary receptors through which the body senses cold.6Frontiers in Pain Research. Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy Patients receiving oxaliplatin are routinely warned to avoid cold drinks, ice, and cold surfaces for days after treatment. Some describe it as the most unexpected and distressing side effect of their entire treatment course, because the sensation can be extreme even in a warm room.
One multicenter trial found that supervised exercise during chemotherapy reduced self-reported hot and cold sensations in the hands and feet compared to a control group, suggesting that physical activity may partially protect nerve function during treatment.3Supportive Care in Cancer. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial That finding is encouraging but modest, and CIPN remains difficult to prevent or reverse once established.
Losing the Body’s Insulation
Cancer cachexia, the progressive wasting of muscle and fat tissue that affects a large proportion of patients with advanced disease, is one of the most underappreciated reasons for feeling cold. The body’s fat layer acts as insulation, and when it shrinks, the body loses heat faster. But cachexia does something more metabolically counterintuitive than simply reducing insulation: it actually converts the body’s remaining white fat into a type of tissue that burns energy as heat.
This process, called fat browning, involves white adipose tissue taking on characteristics of brown fat, a specialized tissue that generates heat by uncoupling cellular energy production from its usual purpose of making usable fuel. In cachectic cancer patients, tumor-derived signaling molecules drive this conversion, causing fat to express higher levels of a protein called UCP1 that diverts energy into heat production rather than storing it.7Cell Metabolism. Astrocytes Promote Tumor Progression Paradoxically, this means the body is burning through its energy reserves at an accelerated rate even as the patient is losing weight and feeling cold. The heat generated by browning fat does not effectively warm the person because the overall energy deficit and loss of insulating tissue overwhelm it.
Tumor-derived parathyroid hormone-related protein (PTHrP) has emerged as one of the key molecules driving this browning process, linking the tumor directly to the metabolic wasting that strips patients of their protective fat layer.8PubMed Central. Cachexia & Brown Fat: A Burning Issue in Cancer Understanding this pathway has opened up research into whether blocking PTHrP could slow or prevent cachexia, though this remains experimental.
Hormonal and Thyroid Disruption
The thyroid gland is a major regulator of metabolic rate and heat production. When thyroid function drops, so does the body’s ability to generate warmth, and patients with hypothyroidism classically report cold intolerance as one of their earliest symptoms. Cancer treatment creates multiple paths to thyroid dysfunction. Radiation therapy aimed at the head, neck, or brain can directly damage the thyroid gland or the pituitary gland that controls it. Certain immunotherapy drugs, particularly checkpoint inhibitors, can trigger autoimmune thyroid inflammation. The result is that a substantial number of cancer survivors end up with some degree of hypothyroidism, which compounds whatever cold sensitivity they already have from other causes.9PubMed Central. Thyroid Disorders in the Oncology Patient
Hormone deprivation therapies used in breast and prostate cancer create a different kind of thermoregulatory chaos. In breast cancer, treatments that suppress estrogen, such as aromatase inhibitors, can provoke symptoms similar to menopause, including vasomotor instability. Most people associate this with hot flashes, and those do occur frequently. But the underlying problem is that the body’s thermoneutral zone, the range of temperatures it can tolerate without actively warming up or cooling down, narrows dramatically when sex hormones are disrupted.10SpringerLink. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages A patient with a narrowed thermoneutral zone bounces between feeling too hot and too cold with little provocation. After a hot flash dissipates, the compensatory cooling can leave someone shivering.
Men on androgen deprivation therapy for prostate cancer face an analogous situation. Testosterone suppression alters metabolic rate and body composition in ways that make heat regulation less stable, and these patients often report both hot flashes and episodes of feeling unusually cold.
Vascular Damage and Reduced Blood Flow
Warm blood circulating to the skin and extremities is one of the body’s primary ways of maintaining a sense of warmth. Several cancer treatments directly damage blood vessels. Many modern chemotherapy drugs, especially those targeting vascular endothelial growth factor (VEGF) signaling, are associated with vascular toxicity including hypertension, blood clots, and impaired endothelial function.11PubMed Central. Vascular Complications of Cancer Chemotherapy When blood vessel linings are damaged and small vessels become less responsive, circulation to the periphery drops. Patients may notice their fingers and toes are persistently cold, even pale or slightly blue, a presentation that can overlap with or worsen the neuropathy described earlier.
Radiation therapy can cause localized vascular damage as well. In irradiated tissues, blood vessels become more permeable and gradually develop fibrosis, stiffening and narrowing over time.12International Journal of Radiation Oncology*Biology*Physics. Late effects of radiation therapy in the head and neck region Patients who received radiation to the chest, for instance, sometimes report persistent cold sensations in the treated area for months or years afterward.13Wolters Kluwer Health / Medicine. A thermal dysregulation problem after breast cancer surgery; what could be? The combination of fibrotic blood vessels, altered nerve function, and scar tissue can make a region of the body feel permanently colder than the surrounding skin.
Why the Chill Compounds Over Time
What makes cold intolerance so persistent for many cancer patients is that these mechanisms stack on top of each other. A patient receiving oxaliplatin-based chemotherapy for colon cancer, for example, may simultaneously experience acute cold hypersensitivity from the drug’s nerve effects, chronic anemia from the disease, muscle and fat loss from early cachexia, and disrupted circadian temperature rhythms from the stress and sleep disruption that accompany treatment. No single one of these causes might be severe enough to explain how cold the patient feels, but together they create a cumulative burden that can be genuinely debilitating.
Nutritional status plays a role too. Many cancer patients eat less, either because of nausea from treatment, altered taste, or reduced appetite from the disease itself. Caloric deficit directly reduces the body’s ability to produce heat. When combined with muscle wasting, which shrinks the tissue most responsible for generating heat through metabolic activity, the body has fewer resources to keep warm and less insulation to retain whatever warmth it does produce.
Age compounds the problem further. Older adults, who make up the majority of cancer patients, already have reduced thermoregulatory capacity compared to younger people. They tend to have less muscle mass, less subcutaneous fat, and less responsive blood vessel dilation and constriction. Adding cancer and its treatments to an already-compromised thermoregulatory system makes cold intolerance more severe and more resistant to simple interventions like adding a blanket.
Practical Approaches That Help
Because the causes are multiple, the solutions need to address more than one pathway. Layered clothing and heated blankets are the most obvious starting point, but they only address heat loss, not heat production. Maintaining physical activity during treatment, to the extent possible, helps preserve muscle mass and has some evidence for reducing nerve-related cold sensitivity.3Supportive Care in Cancer. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial Even light resistance exercises and walking can slow the loss of heat-generating tissue.
Correcting treatable contributors makes a real difference. If anemia is contributing, addressing it through iron supplementation, erythropoiesis-stimulating agents, or transfusion can improve circulation and reduce cold intolerance. Thyroid function should be monitored, especially in patients who have received radiation to the head or neck or immunotherapy drugs known to cause thyroid inflammation, because hypothyroidism is both common and highly treatable with thyroid hormone replacement.9PubMed Central. Thyroid Disorders in the Oncology Patient
For patients dealing with oxaliplatin-specific cold sensitivity, the advice is very practical: avoid cold food, cold drinks, and cold air exposure for several days after infusion. Wearing gloves before reaching into the refrigerator, drinking room-temperature water, and covering the face and hands in cold weather can prevent the acute pain episodes. Some patients wear insulated gloves during infusion as a preventive measure. The acute cold hypersensitivity from oxaliplatin tends to fade between treatment cycles, though cumulative nerve damage from repeated cycles can make it chronic.
Perioperative warming is another area where clinical practice has improved. Cancer patients undergoing surgery are especially vulnerable to hypothermia under anesthesia because their thermoregulatory baseline is already compromised. Research has shown that prewarming patients for as little as 20 minutes before surgery significantly reduces intraoperative temperature drops below 36°C and improves patient-reported thermal comfort during recovery.14PubMed. Impact of Prewarming on Maintaining Perioperative Body Temperature: A Randomized Clinical Trial Techniques like forced-air warming systems and warmed intravenous fluids are now standard in many surgical oncology settings.15PubMed Central. The Effect of Perioperative Thermoregulation on Cancer Surgeries: A Narrative Review
When Cold Intolerance Signals Something Else
Not every chill in a cancer patient is a benign byproduct of treatment. New-onset cold intolerance, especially if it appears suddenly or is asymmetric (affecting one side of the body more than the other), can signal a blood clot, vascular obstruction, or worsening neuropathy that warrants medical evaluation. Patients on anti-VEGF drugs who notice a sudden change in how their hands or feet feel should mention it to their oncology team, because vascular complications from these drugs can be serious.11PubMed Central. Vascular Complications of Cancer Chemotherapy
Severe, persistent cold intolerance that interferes with daily life also deserves a workup for reversible causes. Undiagnosed hypothyroidism, untreated anemia, and nutritional deficiencies are all correctable contributors that sometimes go unaddressed because both patients and clinicians attribute the cold feeling to “just cancer treatment.” It is worth asking whether the thyroid has been checked recently, whether hemoglobin levels have been trending down, or whether caloric intake has dropped. The answer to persistent cold in a cancer patient is rarely “that’s just how it is” – more often, it is several fixable or partially fixable problems layered on top of each other.
Cold Sensitivity After Treatment Ends
One of the most frustrating aspects of cancer-related cold intolerance is that it does not always resolve when treatment stops. CIPN can persist for months or years after the last chemotherapy infusion, particularly in patients who received cumulative high doses of neurotoxic drugs. The nerve damage that underlies cold sensitivity heals slowly, if at all, and some patients are left with permanent changes in how their hands and feet sense temperature.
Survivors who underwent radiation may have localized areas of altered temperature sensation in the treated region for the rest of their lives, a consequence of the fibrotic changes in blood vessels and tissue that radiation causes. Hormonal changes from treatment, whether from thyroid damage, ovarian suppression, or androgen deprivation, may also be long-term or permanent, requiring ongoing hormone replacement to manage symptoms including cold intolerance.
Cachexia-related body composition changes can partially reverse with rehabilitation, good nutrition, and resistance exercise after treatment, but many survivors find that rebuilding muscle mass and fat stores is a slow process. The metabolic shifts driven by tumor-derived signals resolve once the tumor is gone, but the physical deficit they left behind takes time to correct. For survivors who remain in remission, a structured rehabilitation program that includes resistance training and adequate protein intake is one of the most effective long-term strategies for rebuilding the body’s capacity to generate and retain heat.